Martin Capital Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.38M Sell
45,938
-78
-0.2% -$7.49K 1.61% 34
2026
Q1
$4.77M Buy
46,016
+793
+2% +$89.9K 1.77% 34
2025
Q4
$4.56M Buy
45,223
+39,909
+751% +$4.33M 1.72% 32
2025
Q3
$655K Sell
5,314
-301
-5% -$37.4K 0.25% 48
2025
Q2
$674K Buy
5,615
+3,555
+173% +$474K 0.26% 52
2025
Q1
$303K Buy
2,060
+25
+1% +$3.82K 0.36% 49
2024
Q4
$331K Sell
2,035
-17,561
-90% -$2.87M 0.39% 47
2024
Q3
$3.19M Sell
19,596
-6,500
-25% -$963K 1.58% 37
2024
Q2
$3.56M Sell
26,096
-634
-2% -$88K 1.44% 38
2024
Q1
$4.09M Sell
26,730
-109
-0.4% -$16.3K 1.57% 38
2023
Q4
$3.83M Sell
26,839
-391
-1% -$52.1K 1.56% 34
2023
Q3
$3.57M Buy
27,230
+143
+0.5% +$21.7K 1.5% 35
2023
Q2
$4.31M Sell
27,087
-330
-1% -$53.2K 1.75% 31
2023
Q1
$4.34M Buy
27,417
+747
+3% +$112K 1.8% 31
2022
Q4
$3.74M Buy
26,670
+776
+3% +$110K 1.54% 36
2022
Q3
$3.33M Buy
25,894
+1,140
+5% +$164K 1.54% 35
2022
Q2
$3.49M Buy
24,754
+1,163
+5% +$166K 1.66% 36
2022
Q1
$3.28M Buy
23,591
+20,569
+681% +$3.15M 1.5% 36
2021
Q4
$527K Buy
3,022
+57
+2% +$9.5K 0.25% 53
2021
Q3
$491K Buy
2,965
+275
+10% +$47.4K 0.25% 53
2021
Q2
$484K Buy
2,690
+62
+2% +$11.3K 0.25% 53
2021
Q1
$507K Buy
2,628
+573
+28% +$110K 0.27% 52
2020
Q4
$415K Buy
2,055
+125
+6% +$25.9K 0.24% 51
2020
Q3
$406K Sell
1,930
-135
-7% -$30.1K 0.27% 45
2020
Q2
$453K Sell
2,065
-321
-13% -$64.1K 0.32% 41
2020
Q1
$413K Buy
2,386
+3
+0.1% +$496 0.31% 43
2019
Q4
$366K Buy
2,383
+797
+50% +$119K 0.22% 48
2019
Q3
$241K Buy
1,586
+135
+9% +$21.3K 0.16% 48
2019
Q2
$222K Buy
1,451
+8
+0.6% +$1.22K 0.16% 47
2019
Q1
$232K Buy
+1,443
New +$224K 0.18% 46
2018
Q4
Sell
-2,721
Closed -$409K 50
2018
Q3
$409K Buy
+2,721
New +$387K 0.37% 45

Other funds holding CLX

Martin Capital Partners's CLX Position: Q2 2026 in Review

Martin Capital Partners reduced its Clorox (CLX) stake by 0.17% in Q2 2026, selling an estimated $7.49K and leaving 45,938 shares worth $4.38M. The position accounts for 1.61% of the portfolio, ranked #34.

Martin Capital Partners first reported a position in CLX in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.77M in Q1 2026. 202 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Martin Capital Partners held 45,938 shares of Clorox worth $4.38M as of Q2 2026.
  • Martin Capital Partners sold 78 Clorox shares in Q2 2026, an estimated $7.49K.
  • Clorox made up 1.61% of Martin Capital Partners's portfolio in Q2 2026, its #34 holding.
  • Martin Capital Partners first reported a position in Clorox in Q3 2018 and has held it in 31 quarters since.
  • Martin Capital Partners's Clorox position peaked at $4.77M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Martin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.